Free Trial

BioRestorative Therapies (BRTX) Competitors

BioRestorative Therapies logo
$1.48 +0.03 (+2.07%)
(As of 11/22/2024 ET)

BRTX vs. CCM, MRAI, OPGN, PMD, TOI, OTRK, ATIP, MGRX, ATPC, and KDLY

Should you be buying BioRestorative Therapies stock or one of its competitors? The main competitors of BioRestorative Therapies include Concord Medical Services (CCM), Marpai (MRAI), OpGen (OPGN), Psychemedics (PMD), Oncology Institute (TOI), Ontrak (OTRK), ATI Physical Therapy (ATIP), Mangoceuticals (MGRX), Agape ATP (ATPC), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry.

BioRestorative Therapies vs.

Concord Medical Services (NYSE:CCM) and BioRestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, community ranking, earnings and institutional ownership.

BioRestorative Therapies has lower revenue, but higher earnings than Concord Medical Services.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concord Medical Services$471.70M0.04-$41.93MN/AN/A
BioRestorative Therapies$377K27.17-$14.41M-$1.53-0.97

Concord Medical Services received 195 more outperform votes than BioRestorative Therapies when rated by MarketBeat users. However, 100.00% of users gave BioRestorative Therapies an outperform vote while only 62.54% of users gave Concord Medical Services an outperform vote.

CompanyUnderperformOutperform
Concord Medical ServicesOutperform Votes
197
62.54%
Underperform Votes
118
37.46%
BioRestorative TherapiesOutperform Votes
2
100.00%
Underperform Votes
No Votes

Concord Medical Services has a net margin of 0.00% compared to BioRestorative Therapies' net margin of -2,697.08%. Concord Medical Services' return on equity of 0.00% beat BioRestorative Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Concord Medical ServicesN/A N/A N/A
BioRestorative Therapies -2,697.08%-98.49%-75.23%

Concord Medical Services has a beta of -0.27, indicating that its share price is 127% less volatile than the S&P 500. Comparatively, BioRestorative Therapies has a beta of 63.4, indicating that its share price is 6,240% more volatile than the S&P 500.

69.4% of BioRestorative Therapies shares are owned by institutional investors. 46.5% of Concord Medical Services shares are owned by insiders. Comparatively, 25.5% of BioRestorative Therapies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, BioRestorative Therapies had 6 more articles in the media than Concord Medical Services. MarketBeat recorded 7 mentions for BioRestorative Therapies and 1 mentions for Concord Medical Services. BioRestorative Therapies' average media sentiment score of 0.09 beat Concord Medical Services' score of 0.00 indicating that BioRestorative Therapies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Concord Medical Services
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BioRestorative Therapies
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BioRestorative Therapies has a consensus price target of $18.00, suggesting a potential upside of 1,116.22%. Given BioRestorative Therapies' stronger consensus rating and higher probable upside, analysts plainly believe BioRestorative Therapies is more favorable than Concord Medical Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concord Medical Services
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BioRestorative Therapies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

BioRestorative Therapies beats Concord Medical Services on 10 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BRTX vs. The Competition

MetricBioRestorative Therapieshealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$10.24M$2.07B$5.38B$8.84B
Dividend YieldN/A7.23%5.13%4.09%
P/E Ratio-0.9716.00105.1417.83
Price / Sales27.173.291,233.15158.41
Price / CashN/A10.1340.4136.29
Price / Book1.033.897.096.50
Net Income-$14.41M$69.56M$119.65M$226.22M
7 Day Performance2.07%0.89%2.25%4.03%
1 Month Performance-7.50%6.58%-2.33%4.92%
1 Year Performance-20.43%-20.83%33.98%29.30%

BioRestorative Therapies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BRTX
BioRestorative Therapies
3.4739 of 5 stars
$1.48
+2.1%
$18.00
+1,116.2%
-20.4%$10.24M$377,000.00-0.977Gap Up
CCM
Concord Medical Services
0.341 of 5 stars
$4.45
+6.0%
N/A-56.0%$18.24M$471.70M0.00970
MRAI
Marpai
2.0668 of 5 stars
$1.21
-26.2%
$6.00
+395.9%
-31.7%$16.63M$37.15M-0.62150Gap Up
OPGN
OpGen
N/A$1.81
-9.0%
N/A-63.9%$15.13M$3.42M0.00100Gap Down
PMD
Psychemedics
0.8408 of 5 stars
$2.34
flat
N/A+12.0%$13.78M$22.10M-4.57140
TOI
Oncology Institute
2.2827 of 5 stars
$0.16
+14.8%
$2.50
+1,512.9%
-92.3%$11.70M$324.24M-0.20660Gap Up
High Trading Volume
OTRK
Ontrak
2.7403 of 5 stars
$1.83
flat
$45.00
+2,359.0%
-78.7%$7.72M$12.74M-0.17250Negative News
ATIP
ATI Physical Therapy
0.2334 of 5 stars
$1.47
-7.5%
N/A-75.4%$6.48M$699.02M-0.085,600High Trading Volume
MGRX
Mangoceuticals
0.4525 of 5 stars
$2.50
+1.2%
N/A-97.8%$6.23M$730,000.00-0.433Gap Down
ATPC
Agape ATP
0.0125 of 5 stars
$1.52
+5.6%
N/A-93.9%$6.07M$1.43M-2.0840
KDLY
Kindly MD
0.1695 of 5 stars
$0.97
+6.6%
N/AN/A$5.80MN/A0.00N/ALockup Expiration
Gap Up

Related Companies and Tools


This page (NASDAQ:BRTX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners